ESYT3
Extended synaptotagmin-3
Also known as: CHR3SYT, ESYT3_HUMAN, FAM62C
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- A0FGR9
- Gene
- ESYT3
- Ensembl
- ENSG00000158220
- Chromosome
- 3
- Canonical length
- 886 aa
- Protein class
- Predicted membrane proteins, Transporters
OverviewNCBI Gene
Predicted to enable calcium ion binding activity and phospholipid binding activity. Predicted to be involved in endoplasmic reticulum-plasma membrane tethering and lipid transport. Located in cytoplasmic side of plasma membrane; endoplasmic reticulum membrane; and endoplasmic reticulum-plasma membrane contact site. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
886 residues, UniProt reviewed canonical sequence.
>A0FGR9|ESYT3
1 MRAEEPCAPG APSALGAQRT PGPELRLSSQ LLPELCTFVV RVLFYLGPVY LAGYLGLSIT
61 WLLLGALLWM WWRRNRRGKL GRLAAAFEFL DNEREFISRE LRGQHLPAWI HFPDVERVEW
121 ANKIISQTWP YLSMIMESKF REKLEPKIRE KSIHLRTFTF TKLYFGQKCP RVNGVKAHTN
181 TCNRRRVTVD LQICYIGDCE ISVELQKIQA GVNGIQLQGT LRVILEPLLV DKPFVGAVTV
241 FFLQKPHLQI NWTGLTNLLD APGINDVSDS LLEDLIATHL VLPNRVTVPV KKGLDLTNLR
301 FPLPCGVIRV HLLEAEQLAQ KDNFLGLRGK SDPYAKVSIG LQHFRSRTIY RNLNPTWNEV
361 FEFMVYEVPG QDLEVDLYDE DTDRDDFLGS LQICLGDVMT NRVVDEWFVL NDTTSGRLHL
421 RLEWLSLLTD QEVLTEDHGG LSTAILVVFL ESACNLPRNP FDYLNGEYRA KKLSRFARNK
481 VSKDPSSYVK LSVGKKTHTS KTCPHNKDPV WSQVFSFFVH NVATERLHLK VLDDDQECAL
541 GMLEVPLCQI LPYADLTLEQ RFQLDHSGLD SLISMRLVLR FLQVEERELG SPYTGPEALK
601 KGPLLIKKVA TNQGPKAQPQ EEGPTDLPCP PDPASDTKDV SRSTTTTTSA TTVATEPTSQ
661 ETGPEPKGKD SAKRFCEPIG EKKSPATIFL TVPGPHSPGP IKSPRPMKCP ASPFAWPPKR
721 LAPSMSSLNS LASSCFDLAD ISLNIEGGDL RRRQLGEIQL TVRYVCLRRC LSVLINGCRN
781 LTPCTSSGAD PYVRVYLLPE RKWACRKKTS VKRKTLEPLF DETFEFFVPM EEVKKRSLDV
841 AVKNSRPLGS HRRKELGKVL IDLSKEDLIK GFSQWYELTP NGQPRSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ESYT3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.4
- Highest tissue expression
- 6.1 nTPM
Expression across tissuesHPA
Tissue
- skin: 6.1 nTPM
- lung: 4.4 nTPM
- cerebellum: 4.2 nTPM
- thyroid gland: 3.9 nTPM
- colon: 2.9 nTPM
- endometrium: 2 nTPM
Single-cell type
- alveolar cells type 2: 76 nCPM
- alveolar cells type 1: 65 nCPM
- cardiomyocytes: 56 nCPM
- epicardial cells: 39 nCPM
- transitional alveolar cells: 34 nCPM
- gonadotrophs: 24 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebellum: 11 nTPM
- basal ganglia: 5.4 nTPM
- pons: 5.3 nTPM
- thalamus: 5.3 nTPM
- hypothalamus: 5.2 nTPM
- cerebral cortex: 4.6 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.11
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.07
- DepMap mean gene effect
- 0
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- calcium ion binding
- calcium-dependent phospholipid binding
- phosphatidylcholine binding
- phosphatidylethanolamine binding
- phosphatidylinositol binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- C2 domain
- Synaptotagmin-like mitochondrial-lipid-binding domain
- C2 domain superfamily
- Extended synaptotagmin, C2A domain
- Extended synaptotagmin, C2B domain
- Extended synaptotagmin, C-terminal C2 domain
- Synaptotagmin, SMP domain
- Extended Synaptotagmin
- C2 domain
- Synaptotagmin-like mitochondrial-lipid-binding domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ESYT3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ESYT3 as an antibody target. Whether an autoantibody or antibody against ESYT3 could matter depends on whether native ESYT3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ESYT3 is annotated at the cell surface, where native ESYT3 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label ESYT3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...